Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage

• Denis R. Chopera,

  Affiliation Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

  ⨯
• Zenda Woodman,

  Affiliation Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

  ⨯
• Koleka Mlisana,

  Affiliation Centre for the AIDS Programme of Research in South Africa, University of Kwa-Zulu Natal, Durban, South Africa

  ⨯
• Mandla Mlotshwa,

  Affiliation National Institute for Communicable Diseases, Johannesburg, South Africa

  ⨯
• Darren P. Martin,

  Affiliation Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

  ⨯
• Cathal Seoighe,

  Affiliation Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

  ⨯
• Florette Treurnicht,

  Affiliation Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

  ⨯
• Debra Assis de Rosa,

  Affiliation National Institute for Communicable Diseases, Johannesburg, South Africa

  ⨯
• Winston Hide,

  Affiliation South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa

  ⨯
• Salim Abdool Karim,

  Affiliation Centre for the AIDS Programme of Research in South Africa, University of Kwa-Zulu Natal, Durban, South Africa

  ⨯
• Clive M. Gray,

  Affiliation National Institute for Communicable Diseases, Johannesburg, South Africa

  ⨯
• Carolyn Williamson ,

  * E-mail: carolyn.williamson@uct.ac.za

  Affiliation Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

  ⨯
• and the CAPRISA 002 Study Team